C. Touloukian

发表

Identification of CD4+ T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules

S. Rosenberg, Rong-Fu Wang, N. Restifo, 2000, The Journal of Immunology.

Impaired PIASy-Tip60 signaling weakens activation of p53 in melanoma.

S. Kanginakudru, R. Boissy, Samisubbu R. Naidu, 2013, Melanoma research.

Immunization of Patients with Metastatic Melanoma Using Both Class I- and Class II-Restricted Peptides from Melanoma-Associated Antigens

S. Rosenberg, P. Hwu, J. Yang, 2003, Journal of immunotherapy.

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

B. Moss, S. Rosenberg, K. Irvine, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Transgenic Mice Human gp100 Epitope Using DR4-IE Identification of a MHC Class II-Restricted

P. Robbins, N. Restifo, W. Leitner, 2000 .

Normal Tissue Depresses While Tumor Tissue Enhances Human T Cell Responses In Vivo to a Novel Self/Tumor Melanoma Antigen, OA1

A. Sette, S. Rosenberg, R. Schnur, 2003, The Journal of Immunology.

Mining the melanosome for tumor vaccine targets: P.polypeptide is a novel tumor-associated antigen.

S. Rosenberg, P. Robbins, N. Restifo, 2001, Cancer research.

High-avidity Autoreactive CD4+ T Cells Induce Host CTL, Overcome Tregs and Mediate Tumor Destruction

J. Sidney, N. Restifo, W. Leitner, 2009, Journal of immunotherapy.

Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function.

S. Rosenberg, P. Hwu, P. Robbins, 2002, Cancer research.

Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens.

R. Offringa, S. Rosenberg, K. Irvine, 1999, Cancer research.

Advances in Brief Expression of a “ Self-” Antigen by Human Tumor Cells Enhances Tumor Antigen-specific CD 4 T-Cell Function

S. Rosenberg, P. Hwu, P. Robbins, 2002 .

MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells

P. Hwu, P. Robbins, N. Restifo, 2002, Cancer Gene Therapy.

Lotus lectin labels subpopulation of olfactory receptor cells.

W. Stewart, C. Touloukian, 1996, Chemical senses.

Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity.

K. Cornetta, H. Broxmeyer, G. Hangoc, 2010, The Journal of clinical investigation.

Tumor-specific Th17-polarized cells eradicate large established melanoma.

P. Muranski, K. Irvine, N. Restifo, 2008, Blood.

Open Left Colon Resection

K. Ludwig, C. Touloukian, 2003 .

Assumptions of the tumor 'escape' hypothesis.

N. Restifo, P. Antony, M. Theoret, 2002, Seminars in cancer biology.

melanoma Tumor-specific Th17-polarized cells eradicate large established

K. Irvine, N. Restifo, L. Gattinoni, 2011 .

Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.

D. Tyler, S. Perkins, J. Travers, 2014, Cancer research.

Therapeutics , Targets , and Chemical Biology Chemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating Factor

D. Tyler, S. Perkins, J. Travers, 2014 .

The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists.

S. Perkins, M. Kaplan, J. Travers, 2012, Carcinogenesis.

Identification of a MHC Class II-Restricted Human gp100 Epitope Using DR4-IE Transgenic Mice

Steven A. Rosenberg, S. Rosenberg, S. Topalian, 2000, The Journal of Immunology.